spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry giving
its pharma, biotech, and CRO readership expert insight and
analysis on the sponsor-service provider landscape.

EPC focusses on key trends, concerns, and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis
on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-
2015, in a move that brings added value to both brands.
With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas
now have unrivalled access to a wealth of shared views
and analyses.

For further information please contact:

Advertising
Louise White

Editorial
Alex Roberts

We're also on Twitter! Follow us @EPCmagazine


 

 

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

   
epc
 
 
Featured in this issue
Clinical Development
Biomarkers in Clinical Research

Innovative Indication

The benefits of using biomarkers to aid clinical research and data collection are demonstrated by Professor Christene Leiper at Onorach as attention to their use continues to grow.
DATA MANAGEMENT
Subjective Measurements in Dermatology Clinical Trials

A Blemish on Good Science

Bias is a topic that continuously appears throughout clinical trials. Dr Elisabeth Rowold at Novella Clinical suggests that research into data collection strategies can provide reliable and objective data for studies.
  DATA MANAGEMENT
Clinical Data Management

Monitoring and Managing

Praveen Dass at Quanticate provides a comprehensive explanation on how an effective critical data management strategy can drastically enhance clinical trials through results, costs, and timelines.

spacer



Published quarterly in
February, May,
August, and November


 

Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 
News and Press Releases

Wire it with pride with Teknomeks latest modular storage options

Teknomek has extended its modular shelving range to offer customers more options to make optimal use of the storage space available to them. The hygienic units are built from 304 grade stainless steel and feature wire shelving, which does not interrupt air circulation and prevents from dust settling.
More info >>

air transport logo

 

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement